Sientra (STU:S0Z0) Institutional Ownership : 4.83% (As of May. 24, 2024)

View and export this data going back to 2019. Start your Free Trial

What is Sientra Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Sientra's institutional ownership is 4.83%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Sientra's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Sientra's Float Percentage Of Total Shares Outstanding is 98.58%.

Sientra Institutional Ownership Historical Data

The historical data trend for Sientra's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sientra Institutional Ownership Chart

Sientra Historical Data

The historical data trend for Sientra can be seen below:

	2023-04-30	2023-05-31	2023-06-30	2023-07-31	2023-08-31	2023-09-30	2023-10-31	2023-11-30	2023-12-31	2024-01-31
Institutional Ownership	6.70	6.06	6.62	6.70	6.68	6.66	5.04	4.90	4.83	4.83

Sientra Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Sientra (STU:S0Z0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sientra Inc (STU:S0Z0) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

SIEN:USA S0Z0:Germany

Address

3333 Michelson Drive, Suite 650, Irvine, CA, USA, 92612

Website

https://www.sientra.com

Sientra Inc is a part of the healthcare sector in the United States. Its business involves the provision of silicone gel breast implants for use in breast augmentation and breast reconstruction procedures. Its operating segments are Breast Products and miraDry. The Breast Products segment focuses on sales of breast implants, tissue expanders and scar management products under the brands OPUS, AlloX2, Dermaspan, Softspan, and BIOCORNEUM. The miraDry segment focuses on sales of the miraDry System and bioTips. Geographically, the firm generates a majority of its revenue from the United States.

Sientra (STU:S0Z0) Headlines

No Headlines